Abortions (Spontaneous and Elective) and Related Complications — Clinical Documentation Guide (2026)

🔍 Definition

An abortion, in obstetric and medical coding contexts, refers to the termination of a pregnancy before the fetus reaches viability — generally defined as fewer than 20 completed weeks of gestation or a fetal weight under 500 grams (CDC NCHS, Definitions of Vital Statistics). Abortions are broadly classified by etiology (spontaneous vs. induced/elective), completeness (complete vs. incomplete), and the presence or absence of complications. Under FY2026 ICD-10-CM Official Coding Guidelines (Section I.C.15), all obstetric conditions are presumed related to the pregnancy unless the physician documents otherwise.

• Spontaneous abortion (miscarriage): Unintentional, non-induced loss of a pregnancy, classified under category O03. May be complete (all products of conception expelled) or incomplete (partial retention of products of conception).
• Elective/induced termination: Intentional termination of pregnancy by medical or surgical means. Z33.2 is assigned for an encounter for elective termination of pregnancy without complications; O04 is used when complications arise following induced termination.
• Failed attempted termination (O07): Attempted termination that did not result in expulsion, with or without complications.
• Missed abortion (O02.1): Fetal demise without expulsion of products of conception; no cramping or bleeding has occurred.
• Threatened abortion (O20.0): Hemorrhage in early pregnancy with a closed cervical os and a viable intrauterine pregnancy still present.
• Habitual aborter / Recurrent pregnancy loss (N96): Three or more consecutive spontaneous abortions; coded N96 when not currently pregnant.

🗂️ Alternative Terminology

The following terms appear in medical records, operative reports, and physician notes and map to specific ICD-10-CM categories:

🩺 Signs & Symptoms

Clinical presentation varies significantly depending on the type of abortion and presence of complications. Key signs and symptoms that drive code selection include (ACOG Practice Bulletin No. 200 — Early Pregnancy Loss):

• Vaginal bleeding: Ranges from spotting (threatened abortion) to heavy hemorrhage (incomplete/complete); hemorrhage is a key complication flag for O03.1, O03.6
• Pelvic/lower abdominal cramping or pain: Uterine contractions expelling products of conception
• Passage of tissue: Products of conception, gestational sac, or placental tissue — indicates expulsion
• Closed cervical os with bleeding: Hallmark of threatened abortion (O20.0)
• Open/dilated cervical os: Indicative of inevitable or incomplete abortion
• Fever, chills, uterine tenderness: Signs of septic abortion (O03.0, O03.5) — requires urgent intervention
• Hypotension, tachycardia: May indicate septic shock (O03.0, O03.5) or hemorrhagic shock
• Absent fetal cardiac activity on ultrasound with no bleeding: Classic presentation of missed abortion (O02.1)
• Nausea, vomiting: Non-specific; relevant when persistent post-procedure
• Urinary symptoms, oliguria: Suggests renal complications (O03.32, O03.82)

🧭 Differential Diagnosis

Early pregnancy loss and abortion-related presentations may share symptoms with other conditions. The following differential diagnoses are relevant for coders and CDI specialists when documentation is incomplete (American Family Physician — Evaluation and Management of First-Trimester Bleeding):

📋 Clinical Indicators for Coders/CDI

The following clinical indicators determine code assignment specificity and drive CDI queries. Per FY2026 ICD-10-CM Guidelines Section I.C.15.q, abortions require documentation of completeness, trimester (when applicable), and complications to reach maximum specificity.

🦴 Anatomy & Pathophysiology

Understanding the underlying mechanism informs both clinical management and coding specificity.

Normal Early Pregnancy Architecture

At the time of implantation (approximately 6–10 days post-fertilization), the blastocyst embeds in the decidualized endometrium. The trophoblast differentiates into the syncytiotrophoblast and cytotrophoblast, forming the placenta and chorion. The yolk sac and embryo develop within the gestational sac (ACOG Practice Bulletin 200). Human chorionic gonadotropin (hCG) maintains the corpus luteum until the placenta assumes progesterone production.

Pathophysiology of Spontaneous Abortion

Approximately 50–60% of first-trimester spontaneous abortions are caused by chromosomal abnormalities in the embryo (ACOG Practice Bulletin 200). Other etiologies include:

• Chromosomal/genetic factors: Aneuploidy (trisomy 16 most common); accounts for the majority of first-trimester losses
• Uterine anatomic abnormalities: Septate uterus, fibroids, Müllerian anomalies — associated with recurrent pregnancy loss (N96)
• Antiphospholipid antibody syndrome (APS): Leading treatable cause of recurrent loss; hypercoagulable placental environment
• Endocrine disorders: Uncontrolled diabetes, thyroid dysfunction, luteal phase deficiency
• Uterine/cervical incompetence: Painless second-trimester losses; associated with habitual aborter pattern
• Infections: Listeria, Toxoplasma, CMV, group B streptococcus — can precipitate septic abortion

Mechanism of Septic Abortion

Septic abortion occurs when retained products of conception become infected, allowing ascending bacterial contamination (typically polymicrobial — Escherichia coli, Bacteroides, Streptococcus) to progress to endometritis, parametritis, or systemic bacteremia/sepsis. Left untreated, septic shock (O03.0, O03.5) carries significant maternal morbidity and mortality.

Mechanism of Failed Medical Abortion

Medical abortion typically uses mifepristone (progesterone receptor antagonist) followed by misoprostol (prostaglandin E1 analogue). Failure occurs when the embryo is not expelled, the gestational sac remains intact, or incomplete expulsion occurs (O07.x). Failure rates range from 2–5% at recommended gestational ages (FDA-approved labeling for Mifeprex (mifepristone)).

💊 Medication Impact / Treatment

Pharmacologic management is central to both medical abortion and treatment of complications. The following medications directly affect code selection and CDI documentation:

Medical Abortion Regimen

• Mifepristone (Mifeprex): 200 mg oral; antiprogesterone; used in combination with misoprostol for medical abortion up to 70 days gestation. HCPCS S0190 (mifepristone 200 mg). Approved under FDA REMS program (FDA Mifeprex Labeling 2023).
• Misoprostol (Cytotec): 800 mcg buccal/vaginal; prostaglandin E1 analogue; used alone or with mifepristone. No specific HCPCS J-code; billed as unclassified or under NDC-level billing in some states. HCPCS S0191 refers to misoprostol 200 mcg.

Treatment of Incomplete/Septic Abortion

• Oxytocin (Pitocin): Uterotonic to assist expulsion of retained products; reduces hemorrhage
• Methylergonovine (Methergine): Uterotonic; used post-procedure to prevent hemorrhage
• Broad-spectrum antibiotics: Mandatory for septic abortion; typically IV doxycycline + cefoxitin, or metronidazole-based regimens per CDC STI Treatment Guidelines 2021. Document organism, antibiotic use, and response for CDI purposes.
• IV fluid resuscitation / vasopressors: Required in septic shock — document as complication of abortion (O03.0 / O03.5) and code sepsis separately per guidelines
• Rho(D) immune globulin (RhoGAM): Administered to Rh-negative patients following spontaneous or induced abortion to prevent isoimmunization. Not a complication code; add Z29.11 (encounter for prophylactic RhoGAM) if applicable.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following guidelines from the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting (Section I.C.15) govern abortion coding:

General Chapter 15 Principles

• Chapter 15 (O00–O9A) codes apply only to maternal records. The principal diagnosis is always an obstetric code unless the delivery itself is the reason for the encounter.
• Trimester: Assign Z3A.xx (weeks of gestation) as an additional code on all abortion-related encounters where gestational age is documented. First trimester = weeks 1–13 6/7; second trimester = weeks 14–27 6/7.
• Category O03 (Spontaneous abortion): Codes are subdivided first by completeness (incomplete = .0–.4; complete = .5–.9) and then by complication type. Assign the most specific subcategory documented.
• Category O04 (Complications following induced termination): Used ONLY when a complication arises following an induced termination. When the encounter is for the elective termination itself without complications, assign Z33.2 as the principal diagnosis.
• Category O07 (Failed attempted termination): Assign when the attempted termination did not result in expulsion of the pregnancy. Subcodes reflect complications of the failed attempt.
• O02.1 (Missed abortion): Used when the provider documents fetal death without expulsion. Not the same as O03 — missed abortion requires a specific provider statement.
• O20.0 (Threatened abortion): Assign when the provider documents threatened abortion with a viable intrauterine pregnancy confirmed. If the pregnancy subsequently aborts, replace O20.0 with the appropriate O03.x code.
• N96 (Recurrent pregnancy loss): Used only in the non-pregnant state for history of three or more spontaneous abortions. During pregnancy, use O26.2x.

Key Excludes Notes and Code Distinctions

Septic Abortion Coding

Per FY2026 Guidelines Section I.C.15, when sepsis complicates an abortion, assign the appropriate abortion code with the sepsis complication subcategory (e.g., O03.0 or O03.5) as the principal diagnosis. Assign an additional code for the specific organism (e.g., B96.20 for unspecified E. coli) when documented. Septic shock (R65.21) may be assigned as an additional code when documented.

MS-DRG Assignment

Abortion cases are classified primarily in MDC 14 (Pregnancy, Childbirth and Puerperium). Key DRGs include (CMS MS-DRG v43 FY2026):

• DRG 779 — Abortion with D&C, Aspiration Curettage or Hysterotomy: Surgical cases (with procedure)
• DRG 780 — Abortion without D&C: Medical management cases
• Septic abortion with MCC/CC may escalate to higher-weighted DRGs within MDC 14

🔢 ICD-10-CM Code Set (FY2026)

Codes verified against the FY2026 ICD-10-CM Tabular List (CMS):

🔎 Indexing

The following Alphabetic Index entries from the FY2026 ICD-10-CM Alphabetic Index are key reference points:

🏥 CPT (2026)

The following CPT codes are verified for CY2026 per the AMA CPT 2026 Professional Edition. Global periods are as specified in the CMS Physician Fee Schedule.

🧾 HCPCS (2026)

HCPCS Level II codes relevant to medical abortion pharmacotherapy (CMS HCPCS 2026 Release):

📚 AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic for ICD-10-CM/PCS references provide authoritative guidance on abortion coding:

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (implemented CY2024, fully phased in CY2026), most abortion-related codes are acute obstetric episodes and do not map to HCC categories. Risk adjustment under HCC is primarily relevant for Medicare Advantage populations.

Key takeaway: Abortion codes themselves do not contribute to HCC RAF scores. However, serious complications — particularly sepsis (A41.xx), acute kidney injury (N17.x), cardiac arrest, or respiratory failure — when separately documented and coded, do carry HCC weight and should be pursued through CDI query for complete documentation.

✍️ CDI Query Templates

All queries are compliant with AHIMA/ACDIS Guidelines for Physician Queries — non-leading, multiple-choice format with a “clinically undetermined” option.

🧑‍⚕️ Treatments (Clinical)

Clinical management varies by type and stage of abortion. The following treatment pathways are relevant to coding and documentation (ACOG Practice Bulletin 200 — Early Pregnancy Loss; ACOG Practice Bulletin 225 — Medical Management of First-Trimester Abortion):

Spontaneous Abortion — Management Options

• Expectant management: Allow natural expulsion; appropriate for hemodynamically stable patients; monitor with serial hCG and ultrasound
• Medical management: Misoprostol 800 mcg vaginally or buccally; 80–95% complete expulsion rate in first trimester; requires ultrasound follow-up
• Surgical management: Uterine aspiration (manual vacuum aspiration [MVA] or electric vacuum aspiration [EVA]) or D&C; CPT 59812; preferred for hemodynamic instability, infection, or patient preference for speed

Missed Abortion (O02.1)

• Surgical evacuation (CPT 59820 first trimester, 59821 second trimester) or misoprostol medical management
• Ultrasound confirmation of fetal demise required prior to treatment
• Genetic testing of products of conception may be performed to evaluate recurrent loss etiology

Septic Abortion

• IV broad-spectrum antibiotics (see Medication section); initiated promptly
• Urgent uterine evacuation (D&C); CPT 59812
• ICU admission and vasopressor support if septic shock present
• Blood cultures, CBC, comprehensive metabolic panel, lactic acid — document all for coding purposes

Induced Termination (Elective)

• Medical: Mifepristone 200 mg + misoprostol 800 mcg (up to 70 days LMP); FDA-approved regimen; HCPCS S0190 + S0191
• Surgical (first trimester): Uterine aspiration (MVA/EVA); CPT 59840 (D&C) or 59841 (D&E)
• Surgical (second trimester): D&E (CPT 59841); or induction (CPT 59855–59857)
• Pre-operative cervical priming with misoprostol or osmotic dilators may be used; document separately if applicable

Recurrent Pregnancy Loss (N96) — Workup and Treatment

• Comprehensive evaluation: karyotype (both partners), uterine anatomy (HSG, sonohysterogram, hysteroscopy), thrombophilia panel, thyroid function, APS antibodies
• Treatment directed at etiology: low-dose aspirin + heparin for APS; surgical correction for uterine anomalies; progesterone supplementation (investigational)
• Genetic counseling and preimplantation genetic testing (PGT) for couples with chromosomal factors

🎓 Patient Education / Summary

The following patient-facing points summarize key educational content. Coders and CDI specialists may use this section to understand patient context; this does not replace clinical counseling.

• Miscarriage is common: Approximately 10–20% of known pregnancies end in miscarriage, most often due to chromosomal abnormalities in the embryo — not because of anything the patient did (ACOG Patient FAQ — Miscarriage).
• Types of pregnancy loss: Patients should understand the distinction between threatened (pregnancy still viable), missed (baby has stopped growing but no bleeding), incomplete (some tissue remains), and complete (all tissue passed) — because treatment options differ.
• When to seek emergency care: Heavy bleeding (soaking more than one pad per hour for two hours), fever above 100.4°F, severe abdominal pain, or foul-smelling vaginal discharge require immediate evaluation — these may indicate septic abortion, which is a medical emergency.
• Medical abortion options: Patients choosing medication abortion should understand the two-step process (mifepristone + misoprostol), expected timeline, and when to seek follow-up to confirm complete expulsion. FDA-approved patient information is available at FDA Mifeprex Prescribing Information.
• Emotional support: Pregnancy loss — at any stage or for any reason — can be emotionally significant. Resources include the SHARE Pregnancy and Infant Loss Support organization and the RESOLVE: The National Infertility Association for recurrent loss.
• Recurrent pregnancy loss: After three or more miscarriages, evaluation for treatable causes (N96) is recommended. Many causes are identifiable and treatable, with excellent outcomes after appropriate management.
• State-specific laws: Laws governing abortion procedures, medications, and reporting vary significantly by state. Patients and providers should consult current state regulations and, where applicable, legal counsel. Coders must be aware that state-specific reporting requirements may affect documentation needs without altering federal ICD-10-CM code assignment.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)